Weekly Spotlight - 14.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

In the News

Anastrozole Enhances Height in Children with Congenital Adrenal Hyperplasia

Anastrozole shows promise in improving height outcomes for children with congenital adrenal hyperplasia (CAH) due to 21-OHD. By slowing bone maturation, it enhances predicted adult height. This supportive treatment could be a valuable addition for children with advanced bone age, offering hope for better growth prospects.

Primary Adrenal Insufficiency in Children: Insights from Spanish Hospitals

The study on primary adrenal insufficiency in children across five Spanish hospitals highlights the importance of early diagnosis and treatment. It identifies various causes, including X-linked adrenoleukodystrophy and autoimmune adrenalitis. Symptoms like asthenia and hyperpigmentation are common, and timely management can prevent life-threatening adrenal crises.

Adrenal Adenoma Mimicking Non-Classical 21-Hydroxylase Deficiency

The article discusses adrenal adenomas secreting 17-hydroxyprogesterone, which can mimic non-classical 21-hydroxylase deficiency, leading to potential misdiagnosis. It highlights the importance of recognising these rare benign tumours in adrenal steroidogenesis, ensuring accurate diagnosis and treatment, and providing hope for affected individuals through improved understanding and care.